Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian B Hollis

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Journal of Pharmacy Practice|October 21, 2020
Impact of Thrombocytopenia on Postoperative Bleeding Incidence in Patients Receiving Aspirin Following Coronary Artery Bypass GraftingAnne M Rodino, James B Henderson, Kelsey F Dobbins, et al.
Pharmacotherapy|April 5, 2013
Clinical update on the management of atrial fibrillationIlya M Danelich, Brent N Reed, Ian B Hollis, et al.
Pharmacotherapy|August 30, 2019
Predictors of Warfarin Time in Therapeutic Range after Continuous-Flow Left Ventricular Assist DeviceJames B Henderson, Prashanth Iyer, Amanda C Coniglio, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|December 30, 2022
Safety and Efficacy of Prophylactic Amiodarone After Left Ventricular Assist DeviceSydney D T Graboyes, Theresa M Kline, Taylor N Harris, et al.
Artificial Organs|December 15, 2025
Impact of Selective Serotonin Reuptake Inhibitors on Bleeding Rates in HeartMate 3 Left Ventricular Assist Device Patients Not Taking AspirinMadeline Ganter, MaryAnn Bowyer, Emily Relic, et al.
Journal of Pharmacy Practice|September 16, 2022
Safety and Efficacy of Early Post-Operative Intravenous Iron Replacement In Patients With HeartMate III Left Ventricular Assist DeviceRyan M Vesper, Lauren Kemp, Prashanth Iyer, et al.
Journal of Cardiac Failure|March 9, 2010
Continuous versus intermittent infusion of furosemide in acute decompensated heart failureMargaret R Thomson, Jean M Nappi, Steven P Dunn, et al.
Pharmacotherapy|December 22, 2017
PARADIGM-HF Trial: Secondary Analyses Address Unanswered QuestionsKristin R Smith, Chia-Chi Hsu, Theodore J Berei, et al.
Artificial Organs|March 10, 2025
Hemocompatibility-Related Adverse Events Associated With or Without Low Molecular Weight Heparin Bridging in Outpatients With a HeartMate 3 Left Ventricular Assist DeviceJulia R James, Madeline Fuller, Madison Hanford Hunt, et al.
Pharmacotherapy|July 31, 2023
Review of anticoagulation considerations in extracorporeal membrane oxygenation supportSydney D T Graboyes, Phillip S Owen, Rickey A Evans, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of Pharmacy Practice|October 21, 2020
Impact of Thrombocytopenia on Postoperative Bleeding Incidence in Patients Receiving Aspirin Following Coronary Artery Bypass GraftingAnne M Rodino, James B Henderson, Kelsey F Dobbins, et al.
Pharmacotherapy|April 5, 2013
Clinical update on the management of atrial fibrillationIlya M Danelich, Brent N Reed, Ian B Hollis, et al.
Pharmacotherapy|August 30, 2019
Predictors of Warfarin Time in Therapeutic Range after Continuous-Flow Left Ventricular Assist DeviceJames B Henderson, Prashanth Iyer, Amanda C Coniglio, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|December 30, 2022
Safety and Efficacy of Prophylactic Amiodarone After Left Ventricular Assist DeviceSydney D T Graboyes, Theresa M Kline, Taylor N Harris, et al.
Artificial Organs|December 15, 2025
Impact of Selective Serotonin Reuptake Inhibitors on Bleeding Rates in HeartMate 3 Left Ventricular Assist Device Patients Not Taking AspirinMadeline Ganter, MaryAnn Bowyer, Emily Relic, et al.
Journal of Pharmacy Practice|September 16, 2022
Safety and Efficacy of Early Post-Operative Intravenous Iron Replacement In Patients With HeartMate III Left Ventricular Assist DeviceRyan M Vesper, Lauren Kemp, Prashanth Iyer, et al.
Journal of Cardiac Failure|March 9, 2010
Continuous versus intermittent infusion of furosemide in acute decompensated heart failureMargaret R Thomson, Jean M Nappi, Steven P Dunn, et al.
Pharmacotherapy|December 22, 2017
PARADIGM-HF Trial: Secondary Analyses Address Unanswered QuestionsKristin R Smith, Chia-Chi Hsu, Theodore J Berei, et al.
Artificial Organs|March 10, 2025
Hemocompatibility-Related Adverse Events Associated With or Without Low Molecular Weight Heparin Bridging in Outpatients With a HeartMate 3 Left Ventricular Assist DeviceJulia R James, Madeline Fuller, Madison Hanford Hunt, et al.
Pharmacotherapy|July 31, 2023
Review of anticoagulation considerations in extracorporeal membrane oxygenation supportSydney D T Graboyes, Phillip S Owen, Rickey A Evans, et al.
Pageof 3